期刊文献+

486例结直肠癌同时性和异时性肝转移患者的预后分析 被引量:11

Management and prognosis of synchronous and metachronous liver metastasis of colorectal cancer
原文传递
导出
摘要 目的 探讨同时性、异时性结直肠癌肝转移的临床特点及不同治疗策略对患者预后的影响.方法 回顾性分析中山大学附属第一医院1994-2006年结直肠癌数据库中肝转移患者的临床及随访资料.采用Kaplan-Meier法绘制生存曲线,Log-Rank法比较生存率,Cox比例风险回归模型进行多因素分析.结果 共有486例患者发生肝转移,其中同时性肝转移191例,异时性肝转移295例,两组5年生存率差异具有统计学意义(9.3%vs.21.5%,P<0.01);全组患者中267例行手术切除,151例行射频消融治疗,68例保守治疗,三种治疗方法的5年生存率分别为22.1%,10.3%和0,三组之间差异有统计学意义(P<0.01).单因素分析显示,年龄、肝转移类型、术前CEA、原发瘤N分期、分化程度、肠梗阻、腹水、肿瘤直径、治疗策略等因素与患者预后密切相关;多因素分析显示,肝转移类型、术前CEA、腹水、治疗策略是影响预后的独立危险因素. 结论肝转移的不同类型是决定结直肠癌肝转移患者预后的重要因素;根治性手术切除与射频消融、保守治疗相比更能改善结直肠癌肝转移患者预后. Objective To investigate the clinical characteristics and prognosis of patients with synchronous or metachronous liver metastasis of colorectal cancer. Methods Clinical data of patients with colorectal cancer liver metastasis from 1994 to 2006 in the First Affiliated Hospital of Sun Yat-Sen University was retrospectively analyzed. The Kaplan-Meier method and long-rank test were used for bivariate comparisons. Multivariate analysis was done by the Cox regression model (Backward Wald). Results A total of 486 patients with colorectal cancer liver metastasis, including 191 synchronous and 295 metachronous liver metastasis, were analyzed. The overall 5-year cumulative survival rate was 16.2%, 9. 3% forsynchronous and 21.5% for metachronous liver metastasis respectively ( P 〈 0. 01 ). Liver metastasis was surgically resected in 267 patients, 151 received radiofrequency ablation and 68 underwent conservative therapy with 5-year cumulative survival rates of 22. 1%, 10. 3% and 0 ( P 〈 0. 01 ) respectively. On univariate analysis, poor prognosis was associated with older age, synchronous metastasis, higher serum CEA level, advanced N stage and poor differentiation of the primary tumor, bowel obstruction, ascites, tumor longitudinal length over 8cm, non-surgery therapy. Multivariate analysis indicated that synchronous metastasis, serum CEA level, ascites and therapy method were independent prognosis factors. Conclusions The time at which a metastasis occur, serum CEA level,ascites and curative surgical therapy determine the prognosis of patients with colorectal cancer liver metastasis. Surgical resection of metastasis in selected patients could prolong survival.
出处 《中华普通外科杂志》 CSCD 北大核心 2010年第8期635-638,共4页 Chinese Journal of General Surgery
关键词 结直肠肿瘤 肿瘤转移 预后 Colorectal neoplasms Neoplasm metastasis Liver Prognosis
  • 相关文献

参考文献12

  • 1HillingsΦ JG,Wille-JΦrgensen P.Staged or simultaneous resection of synchronous liver metastases from colorectal cancer:a systematic review.Colorectal Dis,2009,11:3-10.
  • 2Manfredi S,Lepage C,Hatem C,et al.Epidemiology and management of liver metastases from colorectal cancer.Ann Surg,2006,244:254-259.
  • 3Scheele J,Stangl R,Altendorf-Hofmann A.Hepatic metastases from colorectal carcinoma:impact of surgical resection on the natural history.Br J Surg,1990,77:1241-1246.
  • 4许剑民,吕世旭.进展期结直肠癌的新辅助治疗[J].中华胃肠外科杂志,2008,11(2):113-115. 被引量:2
  • 5Goldberg RM,Sargent DJ,Morton RF,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.J Clin Oncol,2004,22:23-30.
  • 6Chafai N,Chan CL,Bokey EL,et al.What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis,2005,7:176-181.
  • 7Choti MA,Sitzmann JV,Tiburi MF,et al.Trends in long-term survival following liver resection for hepatic colorectal metastases.Ann Surg,2002,235:759-766.
  • 8Zorzi D,Mullen JT,Abdalla EK,et al.Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.J Gastrointestinal Surg,2006,10:86-94.
  • 9Kenzo Y,Yasuhiro S.Surgical treatment for metastatic malignancies.Anatomical resection of liver metastasis:indications and outcomes.Int J Clin Oncol,2005,10:86-96.
  • 10向军,黄奕华,崔冀,黄美近,王磊,汪建平.同期肝切除治疗结直肠癌同时性肝转移[J].中华普通外科杂志,2007,22(7):507-509. 被引量:4

二级参考文献37

  • 1许剑民,钟芸诗,牛伟新,任黎,赖衍翰,王建华,颜志平,程洁敏,秦新裕.术前肝动脉联合区域动脉灌注化疗预防结直肠癌术后肝转移[J].中华医学杂志,2006,86(2):88-92. 被引量:20
  • 2郁宝铭,张敏,吴唯勤,陈利文,傅骏,费春松,沈英.新辅助放化疗在局部进展期低位直肠癌中的疗效[J].中华外科杂志,2007,45(7):445-448. 被引量:22
  • 3Adam R. Current surgical strategies for the treatment of colorectal cancer liver metastases. EJC Supplements, 2004,2 : 21-26.
  • 4Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg, 2004,240:644-657.
  • 5Barone C, Nuzzo G, Cassano A, et al. Final analysis of colorectal cancer patients treated with irinotecan and 5- fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer, 2007,97:1035-1039.
  • 6Masi G, Cupini S, Marcucci L, et al. Treatment with 5- fluorouracil/of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol, 2006, 13:58-65.
  • 7Ho WM, Ma B, Mok T, et al. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a muhicenter phase H study by the Cancer Therapeutic Research Group. Med Oncol, 2005, 22:303-312.
  • 8Zaniboni A, Torri V, Tinazzi A, et al. Neoadjuvant oxaliplatinbased chemotherapy for liver metastases from colorectal cancer. An Italian survey. Tumori, 2005,91 : 383-387.
  • 9Alberts SR, Horvath WL, Stemfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase H study. J Clin Oncol, 2005, 23 : 9243-9249.
  • 10Lorenz M, Staib-Sebler E, Cog C, et al. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralblatt Fur Chirurgie, 2003,128 : 87-94.

共引文献4

同被引文献139

引证文献11

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部